Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.40 |
| ▸ | F2 | P00734 | 6/20 | 0.40 |
| ▸ | F10 | P00742 | 5/20 | 0.40 |
| ▸ | PLAU | P00749 | 5/20 | 0.40 |
| ▸ | PLAT | P00750 | 5/20 | 0.40 |
| ▸ | PLG | P00747 | 3/20 | 0.40 |
| ▸ | KLK1 | P06870 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6572894 | 0.83 | ALDH1A1 (0.52) | MAPTKDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL6761997 | 0.80 | F10 (0.48) | MAPTKDM4EITGB3ITGA2BF2 | |
| SCHEMBL6571927 | 0.69 | ALDH1A1 (0.47) | MAPTKDM4EITGB3ITGA2BF2 | |
| SCHEMBL6771187 | 0.67 | MAPT (0.38) | MAPTKDM4EITGB3ITGA2BF2 | |
| SCHEMBL6765245 | 0.66 | GAA (0.42) | MAPTITGB3ITGA2BF2F10 | |
| SCHEMBL6762390 | 0.66 | ALDH1A1 (0.46) | MAPTKDM4EITGB3ITGA2BF2 | |
| SCHEMBL7148427 | 0.65 | PRSS1 (0.61) | ITGB3ITGA2BF2PRSS1PRSS2 | |
| SCHEMBL6771396 | 0.65 | PLAU (0.49) | MAPTITGB3ITGA2BF2F10 | |
| SCHEMBL2525700 | 0.64 | PRSS1 (0.62) | ITGB3ITGA2BF2PRSS1PRSS2 | |
| SCHEMBL14599554 | 0.64 | PRSS1 (0.71) | ITGB3ITGA2BF2F10PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040248897-A1 | Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248897-A1 | Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions | NAT1, CYP3A5, CYP3A7 | MAPT 449/4885KDM4E 1576/4885ITGB3 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.